n/a (BHC.TO)

: BHC.TO · 실시간 가격 · USD

n/a

n/a (n/a)

종가 기준: Invalid Date

데이터 없음

매수호가	n/a
시가총액	n/a
매출 (ttm)	n/a
순이익 (ttm)	n/a
베타	n/a
EPS (ttm)	n/a
P/E (ttm)	n/a
선행 P/E	n/a
P/B (ttm)	n/a
P/S (ttm)	n/a
Earnings Date	n/a

매도호가	n/a
거래량	NaN
평균 거래량 (20일)	n/a
시가	n/a
전일 종가	n/a
일중 범위	n/a - n/a
52주 범위	n/a - n/a
애널리스트	n/a
목표주가	n/a
배당	n/a
배당락일	n/a

BHC.TO 소개

A detailed description of the company is not yet available....

[더 보기]

산업 n/a

섹터 n/a

IPO 일자 n/a

직원 수 n/a

상장 거래소 n/a

티커 BHC.TO

전체 기업 정보

어닝 서프라이즈

가 Jul 29, 2026에 분기 실적을 발표했습니다:

매출 $2.85B 예상치 하회 $0, 및 12.73% 전년 대비 성장.

EPS 1.26 예상치 상회 0.25, 및 38.46% 전년 대비 성장.

뉴스

1주 전 · Motley Fool

Why Bausch Health Companies Stock Skyrocketed by Almost 40% Last Month

Much of this was due to a very well-received quarterly earnings report.

2주 전 · Insider Monkey

Bausch Health (BHC) Rockets 28% as Q2 Turnaround Fuels Recovery Outlook

Bausch Health (NYSE:BHC) climbed by 28.85 percent on Thursday to end at $6.03 apiece, after announcing a strong second quarter of the year that set the ground for the company’s profit recovery. In an ...

2주 전 · Zacks

BHC Q2 Earnings Beat Estimates on Salix and Solta Growth, '26 View Raised

BHC beats Q2 estimates as Salix, Solta Medical and Bausch + Lomb fuel growth, lifting 2026 revenue and EBITDA guidance after strong earnings.

2주 전 · Moby

Bausch Health Companies Inc. Q2 2026 Earnings Call Summary

Moby summary of Bausch Health Companies Inc.'s Q2 2026 earnings call

2주 전 · MarketBeat

Bausch Health Cos Q2 Earnings Call Highlights

Bausch Health Cos (NYSE:BHC) reported second-quarter results that management said extended its streak of revenue and adjusted EBITDA growth to 13 consecutive quarters, driven by performance in its Sal...

2 페이지 중 1